The non-scientific review was untaken after the event of closure (>1 year from memory??). It was then completely debunked with an actual expert's report during arbitration.
No due process and no evidence. In fact we showed evidence of ongoing monitoring (blood tests) and quarterly DPIM audits.
Check mate and not really even worth discussing.
Short Squeeze on Sale of Neuva Esperanza or 1st Gold pour, page-27
Add KCN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.56 |
Change
-0.020(1.27%) |
Mkt cap ! $402.0M | |||
| Open | High | Low | Value | Volume |
| $1.59 | $1.60 | $1.56 | $685.1K | 435.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9998 | $1.56 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.58 | 2724 | 2 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.57 |
Change
-0.020 ( 1.26 %) |
||||
| Open | High | Low | Volume | ||
| $1.57 | $1.60 | $1.56 | 17710 | ||
| Last updated 15.16pm 14/06/2024 ? | |||||
| KCN (ASX) Chart |